-
Key Findings \n1.3. Market Segmentation \n1.4. Competitive Landscape \n1.5. Challenges
-
and Opportunities \n1.6. Future Outlook \n\n\n\n2. MARKET INTRODUCTION \n2.1. Definition
-
\n2.2. Scope of the study \n2.2.1. Research Objective \n2.2.2. Assumption \n2.2.3.
-
Limitations \n3. RESEARCH METHODOLOGY \n3.1. Overview \n3.2. Data Mining \n3.3.
-
Secondary Research \n3.4. Primary Research \n3.4.1. Primary Interviews and Information
-
Gathering Process \n3.4.2. Breakdown of Primary Respondents \n3.5. Forecasting Model
-
\n3.6. Market Size Estimation \n3.6.1. Bottom-Up Approach \n3.6.2. Top-Down Approach
-
\n3.7. Data Triangulation \n3.8. Validation \n\n\n\n4. MARKET DYNAMICS \n4.1. Overview
-
\n4.2. Drivers \n4.3. Restraints \n4.4. Opportunities \n5. MARKET FACTOR ANALYSIS
-
\n5.1. Value chain Analysis \n5.2. Porter's Five Forces Analysis \n5.2.1. Bargaining
-
Power of Suppliers \n5.2.2. Bargaining Power of Buyers \n5.2.3. Threat of New Entrants
-
\n5.2.4. Threat of Substitutes \n5.2.5. Intensity of Rivalry \n5.3. COVID-19 Impact
-
Analysis \n5.3.1. Market Impact Analysis \n5.3.2. Regional Impact \n5.3.3. Opportunity
-
and Threat Analysis \n\n\n\n6. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET,
-
BY COMPONENT (USD BILLION) \n6.1. Hardware \n6.2. Software \n6.3. Services \n7.
-
INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY APPLICATION (USD BILLION)
-
\n7.1. Robot-Assisted Surgery \n7.2. Virtual Nursing Assistant \n7.3. Dosage Error
-
Reduction \n7.4. Clinical Trial \n7.5. Preliminary Diagnosis \n7.6. Automated Image
-
Diagnosis \n8. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY TECHNOLOGY
-
(USD BILLION) \n8.1. Machine Learning \n8.2. Querying Method \n8.3. Natural Language
-
Processing \n9. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY END-USER
-
(USD BILLION) \n9.1. Hospital Diagnostic Centers \n9.2. Pharmaceutical Biotechnology
-
Companies \n9.3. Academic Research Laboratories \n\n\n\n10. COMPETITIVE LANDSCAPE
-
\n10.1. Overview \n10.2. Competitive Analysis \n10.3. Market share Analysis \n10.4.
-
Major Growth Strategy in the Healthcare Artificial Intelligence (AI) Market \n10.5.
-
Competitive Benchmarking \n10.6. Leading Players in Terms of Number of Developments
-
in the Healthcare Artificial Intelligence (AI) Market \n10.7. Key developments and
-
growth strategies \n10.7.1. New Product Launch/Service Deployment \n10.7.2. Merger
-
Acquisitions \n10.7.3. Joint Ventures \n10.8. Major Players Financial Matrix \n10.8.1.
-
Sales and Operating Income \n10.8.2. Major Players RD Expenditure. 2023 \n11. COMPANY
-
PROFILES \n11.1. HealthifyMe \n11.1.1. Financial Overview \n11.1.2. Products Offered
-
\n11.1.3. Key Developments \n11.1.4. SWOT Analysis \n11.1.5. Key Strategies \n11.2.
-
Tata Consultancy Services \n11.2.1. Financial Overview \n11.2.2. Products Offered
-
\n11.2.3. Key Developments \n11.2.4. SWOT Analysis \n11.2.5. Key Strategies \n11.3.
-
Zebra Medical Vision \n11.3.1. Financial Overview \n11.3.2. Products Offered \n11.3.3.
-
Key Developments \n11.3.4. SWOT Analysis \n11.3.5. Key Strategies \n11.4. Niramai
-
\n11.4.1. Financial Overview \n11.4.2. Products Offered \n11.4.3. Key Developments
-
\n11.4.4. SWOT Analysis \n11.4.5. Key Strategies \n11.5. IBM Watson Health \n11.5.1.
-
Financial Overview \n11.5.2. Products Offered \n11.5.3. Key Developments \n11.5.4.
-
SWOT Analysis \n11.5.5. Key Strategies \n11.6. Siemens Healthineers \n11.6.1. Financial
-
Overview \n11.6.2. Products Offered \n11.6.3. Key Developments \n11.6.4. SWOT Analysis
-
\n11.6.5. Key Strategies \n11.7. Philips Healthcare \n11.7.1. Financial Overview
-
\n11.7.2. Products Offered \n11.7.3. Key Developments \n11.7.4. SWOT Analysis \n11.7.5.
-
Key Strategies \n11.8. CureMetrix \n11.8.1. Financial Overview \n11.8.2. Products
-
Offered \n11.8.3. Key Developments \n11.8.4. SWOT Analysis \n11.8.5. Key Strategies
-
\n11.9. GE Healthcare \n11.9.1. Financial Overview \n11.9.2. Products Offered \n11.9.3.
-
Key Developments \n11.9.4. SWOT Analysis \n11.9.5. Key Strategies \n11.10. Bristol
-
Myers Squibb \n11.10.1. Financial Overview \n11.10.2. Products Offered \n11.10.3.
-
Key Developments \n11.10.4. SWOT Analysis \n11.10.5. Key Strategies \n11.11. SigTuple
-
\n11.11.1. Financial Overview \n11.11.2. Products Offered \n11.11.3. Key Developments
-
\n11.11.4. SWOT Analysis \n11.11.5. Key Strategies \n11.12. Wipro \n11.12.1. Financial
-
Overview \n11.12.2. Products Offered \n11.12.3. Key Developments \n11.12.4. SWOT
-
Analysis \n11.12.5. Key Strategies \n11.13. HCL Technologies \n11.13.1. Financial
-
Overview \n11.13.2. Products Offered \n11.13.3. Key Developments \n11.13.4. SWOT
-
Analysis \n11.13.5. Key Strategies \n11.14. Qure.ai \n11.14.1. Financial Overview
-
\n11.14.2. Products Offered \n11.14.3. Key Developments \n11.14.4. SWOT Analysis
-
\n11.14.5. Key Strategies \n12. APPENDIX \n12.1. References \n12.2. Related Reports
-
\nLIST OF TABLES\n\nTABLE 1. LIST OF ASSUMPTIONS \nTABLE 2. INDIA HEALTHCARE ARTIFICIAL
-
INTELLIGENCE (AI) MARKET SIZE ESTIMATES & FORECAST, BY COMPONENT, 2019-2035
-
(USD BILLIONS) \nTABLE 3. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SIZE
-
ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) \nTABLE 4. INDIA
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SIZE ESTIMATES & FORECAST, BY
-
TECHNOLOGY, 2019-2035 (USD BILLIONS) \nTABLE 5. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE
-
(AI) MARKET SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2035 (USD BILLIONS)
-
\nTABLE 6. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL \nTABLE 7. ACQUISITION/PARTNERSHIP
-
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLIST OF FIGURES\n\nFIGURE
-
MARKET SYNOPSIS \nFIGURE 2. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET
-
ANALYSIS BY COMPONENT \nFIGURE 3. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE (AI)
-
MARKET ANALYSIS BY APPLICATION \nFIGURE 4. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE
-
(AI) MARKET ANALYSIS BY TECHNOLOGY \nFIGURE 5. INDIA HEALTHCARE ARTIFICIAL INTELLIGENCE
-
(AI) MARKET ANALYSIS BY END-USER \nFIGURE 6. KEY BUYING CRITERIA OF HEALTHCARE ARTIFICIAL
-
INTELLIGENCE (AI) MARKET \nFIGURE 7. RESEARCH PROCESS OF MRFR \nFIGURE 8. DRO ANALYSIS
-
OF HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET \nFIGURE 9. DRIVERS IMPACT ANALYSIS:
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET \nFIGURE 10. RESTRAINTS IMPACT ANALYSIS:
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET \nFIGURE 11. SUPPLY / VALUE CHAIN:
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET \nFIGURE 12. HEALTHCARE ARTIFICIAL
-
INTELLIGENCE (AI) MARKET, BY COMPONENT, 2024 (% SHARE) \nFIGURE 13. HEALTHCARE ARTIFICIAL
-
INTELLIGENCE (AI) MARKET, BY COMPONENT, 2019 TO 2035 (USD Billions) \nFIGURE 14.
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY APPLICATION, 2024 (% SHARE) \nFIGURE
-
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY APPLICATION, 2019 TO 2035
-
(USD Billions) \nFIGURE 16. HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY TECHNOLOGY,
-
(% SHARE) \nFIGURE 17. HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET, BY TECHNOLOGY,
-
TO 2035 (USD Billions) \nFIGURE 18. HEALTHCARE ARTIFICIAL INTELLIGENCE (AI)
-
MARKET, BY END-USER, 2024 (% SHARE) \nFIGURE 19. HEALTHCARE ARTIFICIAL INTELLIGENCE
-
(AI) MARKET, BY END-USER, 2019 TO 2035 (USD Billions) \nFIGURE 20. BENCHMARKING
-
OF MAJOR COMPETITORS